Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Discovery of widespread Type I and Type V CRISPR-Cas inhibitors.

Marino ND, Zhang JY, Borges AL, Sousa AA, Leon LM, Rauch BJ, Walton RT, Berry JD, Joung JK, Kleinstiver BP, Bondy-Denomy J.

Science. 2018 Sep 6. pii: eaau5174. doi: 10.1126/science.aau5174. [Epub ahead of print]

PMID:
30190308
2.

Phage morons play important roles in controlling Pseudomonas aeruginosa phenotypes.

Tsao YF, Taylor VL, Kala S, Bondy-Denomy J, Khan AN, Bona D, Cattoir V, Lory S, Davidson AR, Maxwell KL.

J Bacteriol. 2018 Aug 27. pii: JB.00189-18. doi: 10.1128/JB.00189-18. [Epub ahead of print]

PMID:
30150232
3.

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.

Borges AL, Zhang JY, Rollins MF, Osuna BA, Wiedenheft B, Bondy-Denomy J.

Cell. 2018 Aug 9;174(4):917-925.e10. doi: 10.1016/j.cell.2018.06.013. Epub 2018 Jul 19.

PMID:
30033364
4.

Protein Inhibitors of CRISPR-Cas9.

Bondy-Denomy J.

ACS Chem Biol. 2018 Feb 16;13(2):417-423. doi: 10.1021/acschembio.7b00831. Epub 2018 Jan 17.

PMID:
29251498
5.

How bacteria control the CRISPR-Cas arsenal.

Leon LM, Mendoza SD, Bondy-Denomy J.

Curr Opin Microbiol. 2018 Apr;42:87-95. doi: 10.1016/j.mib.2017.11.005. Epub 2017 Nov 21. Review.

PMID:
29169146
6.

Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation.

Harvey H, Bondy-Denomy J, Marquis H, Sztanko KM, Davidson AR, Burrows LL.

Nat Microbiol. 2018 Jan;3(1):47-52. doi: 10.1038/s41564-017-0061-y. Epub 2017 Nov 13.

PMID:
29133883
7.

The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.

Borges AL, Davidson AR, Bondy-Denomy J.

Annu Rev Virol. 2017 Sep 29;4(1):37-59. doi: 10.1146/annurev-virology-101416-041616. Epub 2017 Jul 27. Review.

8.

Disabling Cas9 by an anti-CRISPR DNA mimic.

Shin J, Jiang F, Liu JJ, Bray NL, Rauch BJ, Baik SH, Nogales E, Bondy-Denomy J, Corn JE, Doudna JA.

Sci Adv. 2017 Jul 12;3(7):e1701620. doi: 10.1126/sciadv.1701620. eCollection 2017 Jul.

9.

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

Rollins MF, Chowdhury S, Carter J, Golden SM, Wilkinson RA, Bondy-Denomy J, Lander GC, Wiedenheft B.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5113-E5121. doi: 10.1073/pnas.1616395114. Epub 2017 Apr 24.

10.

Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex.

Chowdhury S, Carter J, Rollins MF, Golden SM, Jackson RN, Hoffmann C, Nosaka L, Bondy-Denomy J, Maxwell KL, Davidson AR, Fischer ER, Lander GC, Wiedenheft B.

Cell. 2017 Mar 23;169(1):47-57.e11. doi: 10.1016/j.cell.2017.03.012.

11.

CRISPR control of virulence in Pseudomonas aeruginosa.

Wiedenheft B, Bondy-Denomy J.

Cell Res. 2017 Feb;27(2):163-164. doi: 10.1038/cr.2017.6. Epub 2017 Jan 13.

12.

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.

Rauch BJ, Silvis MR, Hultquist JF, Waters CS, McGregor MJ, Krogan NJ, Bondy-Denomy J.

Cell. 2017 Jan 12;168(1-2):150-158.e10. doi: 10.1016/j.cell.2016.12.009. Epub 2016 Dec 29.

13.

Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system.

Høyland-Kroghsbo NM, Paczkowski J, Mukherjee S, Broniewski J, Westra E, Bondy-Denomy J, Bassler BL.

Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):131-135. doi: 10.1073/pnas.1617415113. Epub 2016 Nov 14.

14.

The solution structure of an anti-CRISPR protein.

Maxwell KL, Garcia B, Bondy-Denomy J, Bona D, Hidalgo-Reyes Y, Davidson AR.

Nat Commun. 2016 Oct 11;7:13134. doi: 10.1038/ncomms13134.

15.

Prophages mediate defense against phage infection through diverse mechanisms.

Bondy-Denomy J, Qian J, Westra ER, Buckling A, Guttman DS, Davidson AR, Maxwell KL.

ISME J. 2016 Dec;10(12):2854-2866. doi: 10.1038/ismej.2016.79. Epub 2016 Jun 3.

16.

The diversity-generating benefits of a prokaryotic adaptive immune system.

van Houte S, Ekroth AK, Broniewski JM, Chabas H, Ashby B, Bondy-Denomy J, Gandon S, Boots M, Paterson S, Buckling A, Westra ER.

Nature. 2016 Apr 21;532(7599):385-8. doi: 10.1038/nature17436. Epub 2016 Apr 13.

17.

Active and adaptive Legionella CRISPR-Cas reveals a recurrent challenge to the pathogen.

Rao C, Guyard C, Pelaz C, Wasserscheid J, Bondy-Denomy J, Dewar K, Ensminger AW.

Cell Microbiol. 2016 Oct;18(10):1319-38. doi: 10.1111/cmi.12586. Epub 2016 Mar 31.

18.

Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.

Vorontsova D, Datsenko KA, Medvedeva S, Bondy-Denomy J, Savitskaya EE, Pougach K, Logacheva M, Wiedenheft B, Davidson AR, Severinov K, Semenova E.

Nucleic Acids Res. 2015 Dec 15;43(22):10848-60. doi: 10.1093/nar/gkv1261. Epub 2015 Nov 19.

19.

Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.

Bondy-Denomy J, Garcia B, Strum S, Du M, Rollins MF, Hidalgo-Reyes Y, Wiedenheft B, Maxwell KL, Davidson AR.

Nature. 2015 Oct 1;526(7571):136-9. doi: 10.1038/nature15254. Epub 2015 Sep 23.

20.

Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense.

Westra ER, van Houte S, Oyesiku-Blakemore S, Makin B, Broniewski JM, Best A, Bondy-Denomy J, Davidson A, Boots M, Buckling A.

Curr Biol. 2015 Apr 20;25(8):1043-9. doi: 10.1016/j.cub.2015.01.065. Epub 2015 Mar 12.

21.

A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.

Pawluk A, Bondy-Denomy J, Cheung VH, Maxwell KL, Davidson AR.

MBio. 2014 Apr 15;5(2):e00896. doi: 10.1128/mBio.00896-14.

22.

When a virus is not a parasite: the beneficial effects of prophages on bacterial fitness.

Bondy-Denomy J, Davidson AR.

J Microbiol. 2014 Mar;52(3):235-42. doi: 10.1007/s12275-014-4083-3. Epub 2014 Mar 1. Review.

PMID:
24585054
23.

To acquire or resist: the complex biological effects of CRISPR-Cas systems.

Bondy-Denomy J, Davidson AR.

Trends Microbiol. 2014 Apr;22(4):218-25. doi: 10.1016/j.tim.2014.01.007. Epub 2014 Feb 26. Review.

PMID:
24582529
24.

Efficacy of bacteriophage treatment on Pseudomonas aeruginosa biofilms.

Phee A, Bondy-Denomy J, Kishen A, Basrani B, Azarpazhooh A, Maxwell K.

J Endod. 2013 Mar;39(3):364-9. doi: 10.1016/j.joen.2012.10.023. Epub 2012 Nov 28.

PMID:
23402508
25.

Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.

Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR.

Nature. 2013 Jan 17;493(7432):429-32. doi: 10.1038/nature11723. Epub 2012 Dec 16.

26.

The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages.

Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA.

J Bacteriol. 2012 Nov;194(21):5728-38. doi: 10.1128/JB.01184-12. Epub 2012 Aug 10.

27.

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

Stanford MM, Shaban M, Barrett JW, Werden SJ, Gilbert PA, Bondy-Denomy J, Mackenzie L, Graham KC, Chambers AF, McFadden G.

Mol Ther. 2008 Jan;16(1):52-9. Epub 2007 Nov 13.

Supplemental Content

Loading ...
Support Center